A Subset of Patients with Acute Myeloid Leukemia Has Leukemia Cells Characterized by Chemokine Responsiveness and Altered Expression of Transcriptional as well as Angiogenic Regulators

Acute myeloid leukemia (AML) is an aggressive and heterogeneous bone marrow malignancy, the only curative treatment being intensive chemotherapy eventually in combination with allogeneic stem cell transplantation. Both the AML and their neighboring stromal cells show constitutive chemokine release,...

Descripción completa

Detalles Bibliográficos
Autores principales: Brenner, Annette K., Reikvam, Håkon, Bruserud, Øystein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879142/
https://www.ncbi.nlm.nih.gov/pubmed/27252705
http://dx.doi.org/10.3389/fimmu.2016.00205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879142/
https://www.ncbi.nlm.nih.gov/pubmed/27252705
http://dx.doi.org/10.3389/fimmu.2016.00205

Ejemplares similares